| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/02/2023 | Immunome Inc. | IMNM | Grant | Common Stock | 253.8k | $5.91 | $1.5M | | 10/02/2023 |
| 06/08/2023 | Immunome Inc. | IMNM | Grant | Stock Option (Right to Buy) | 6.5k | $4.84 | $31.5k | | 06/08/2023 |
| 01/15/2023 | Immunome Inc. | IMNM | Grant | Common Stock | 17.5k | $4.00 | $70k | | 01/15/2023 |
| 06/16/2022 | Immunome Inc. | IMNM | Grant | Stock Option (Right to Buy) | 6.5k | $2.62 | $17k | | 06/16/2022 |
| 09/13/2021 | Immunome Inc. | IMNM | Purchase | Common Stock | 26k | $19.96 | $518.2k | See Footnote | 09/13/2021 |
| 09/10/2021 | Immunome Inc. | IMNM | Purchase | Common Stock | 15.5k | $17.85 | $276.7k | See Footnote | 09/09/2021 |
| 09/09/2021 | Immunome Inc. | IMNM | Purchase | Common Stock | 8.2k | $17.44 | $142.5k | See Footnote | 09/09/2021 |
| 09/09/2021 | Immunome Inc. | IMNM | Purchase | Common Stock | 22.3k | $18.46 | $411.3k | See Footnote | 09/09/2021 |
| 05/28/2021 | Immunome Inc. | IMNM | Grant | Stock Option (Right to Buy) | 3.8k | $20.92 | $78.4k | | 05/28/2021 |
| 05/26/2021 | Immunome Inc. | IMNM | Purchase | Common Stock | 2.3k | $18.94 | $43.6k | See Footnote | 05/24/2021 |
| 05/25/2021 | Immunome Inc. | IMNM | Purchase | Common Stock | 19.3k | $18.32 | $353.6k | See Footnote | 05/24/2021 |
| 05/24/2021 | Immunome Inc. | IMNM | Purchase | Common Stock | 31.9k | $18.38 | $586.2k | See Footnote | 05/24/2021 |
| 11/03/2020 | Immunome Inc. | IMNM | Grant | | 7.5k | $11.38 | $85.4k | | 11/03/2020 |
| 10/06/2020 | Immunome Inc. | IMNM | Conversion | Warrant (right to buy) | 166.7k | $9.00 | $1.5M | | 10/06/2020 |
| 10/06/2020 | Immunome Inc. | IMNM | Conversion | Series A Convertible Preferred Stock | 555.6k | $0.00 | $0 | | 10/06/2020 |
| 10/06/2020 | Immunome Inc. | IMNM | Purchase | Common Stock | 83.3k | $12.00 | $1000k | | 10/06/2020 |
| 10/06/2020 | Immunome Inc. | IMNM | Conversion | Common Stock | 555.6k | $0.00 | $0 | | 10/06/2020 |
| 05/30/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | Purchase | Common Stock | 5.9k | $10.45 | $61.5k | | 05/30/2018 |
| 05/02/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | Purchase | Common Stock | 15k | $10.46 | $156.9k | | 03/22/2018 |
| 03/22/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | Purchase | Common Stock | 10k | $9.28 | $92.8k | | 03/22/2018 |
| 01/02/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | Purchase | Common Stock | 15k | $12.99 | $194.8k | | 01/02/2018 |
| 10/23/2017 | Zynerba Pharmaceuticals, Inc. | ZYNE | Purchase | Common Stock | 25.7k | $9.94 | $255.8k | | 10/19/2017 |
| 10/20/2017 | Zynerba Pharmaceuticals, Inc. | ZYNE | Purchase | Common Stock | 30k | $9.78 | $293.5k | | 10/19/2017 |
| 10/19/2017 | Zynerba Pharmaceuticals, Inc. | ZYNE | Purchase | Common Stock | 44.3k | $9.59 | $424.4k | | 10/19/2017 |
| 12/29/2016 | Zynerba Pharmaceuticals, Inc. | ZYNE | Purchase | Common Stock | 10k | $15.85 | $158.5k | | 12/29/2016 |
| 02/02/2016 | Zynerba Pharmaceuticals, Inc. | ZYNE | Other (acquisition) | Common Stock | 80.5k | $0.00 | $0 | | 02/02/2016 |
| 08/10/2015 | Zynerba Pharmaceuticals, Inc. | ZYNE | Conversion | Common Stock | 567.5k | $0.00 | $0 | | 08/10/2015 |
| 08/10/2015 | Zynerba Pharmaceuticals, Inc. | ZYNE | Conversion | Series 1 Convertible Preferred Stock | 1.1M | $0.00 | $0 | | 08/10/2015 |
| 06/19/2012 | ONE Group Hospitality, Inc. | STKS | Other (acquisition) | | 93.2k | $0.00 | $0 | See Footnote | 06/19/2012 |
| 06/19/2012 | ONE Group Hospitality, Inc. | STKS | Other (disposition) | | 176k | $0.00 | $0 | | 06/19/2012 |